News & Updates

Ageing linked to seronegativity in RA
Ageing linked to seronegativity in RA
29 Mar 2023

Ageing is independently associated with seronegative rheumatoid arthritis (RA) in patients who are female, have a nonsmoking history, and a body mass index (BMI) <25 kg/m2, according to a study.

Ageing linked to seronegativity in RA
29 Mar 2023
Short-term risk of certain cancers similar in RA, PsA patients treated with JAK, TNF inhibitors
Short-term risk of certain cancers similar in RA, PsA patients treated with JAK, TNF inhibitors
12 Mar 2023

For patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), initiation of Janus kinase (JAK) inhibitor treatment does not carry a higher short-term risk of cancer, with the exception of nonmelanoma skin cancer (NMSC), as compared with initiation of biological disease-modifying antirheumatic drugs (bDMARDs) including tumour necrosis factor (TNF) inhibitors, according to a study.

Short-term risk of certain cancers similar in RA, PsA patients treated with JAK, TNF inhibitors
12 Mar 2023
Vaccination offers protection to AIIRD patients, but only a few get vaxxed
Vaccination offers protection to AIIRD patients, but only a few get vaxxed
05 Mar 2023

Vaccines are safe and effective in patients with autoimmune inflammatory rheumatic disease (AIIRD), according to several physicians who participated in a recent international survey. However, many of the respondents are also responsible for not encouraging their patients to get vaccinated.

Vaccination offers protection to AIIRD patients, but only a few get vaxxed
05 Mar 2023
How common is viral burden rebound in hospitalized COVID-19 patients with or without oral antiviral treatment?
How common is viral burden rebound in hospitalized COVID-19 patients with or without oral antiviral treatment?
03 Mar 2023 bySarah Cheung

A real-world study during Hong Kong’s Omicron BA.2.2 wave has shown that viral burden rebound is uncommon in hospitalized COVID-19 patients not requiring supplemental oxygen on admission, regardless of whether they were treated with nirmatrelvir/ritonavir or molnupiravir. However, immunocompromised patients, regardless of oral antiviral use, are more likely to have viral burden rebound.

How common is viral burden rebound in hospitalized COVID-19 patients with or without oral antiviral treatment?
03 Mar 2023
Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE
Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE
09 Feb 2023

Young patients with newly diagnosed systemic lupus erythematosus (SLE) are vulnerable to psychiatric comorbidity, which tends to increase healthcare utilization, according to a study.

Psychiatric comorbidity boosts healthcare use in youth with newly diagnosed SLE
09 Feb 2023